XDH and hyperuricemia: In light of the current evidence, the multifactorial mechanism linking hyperuricemia to cardiovascular and renal diseases involves both SUA level and XO activity [12], with the XO inhibitors (XOIs) being the most potent available UA-lowering drugs, with documented beneficial effects on both cardiovascular and renal systems [13].